nodes	percent_of_prediction	percent_of_DWPC	metapath
Metolazone—Abdominal distension—Methylprednisolone—psoriatic arthritis	0.00424	0.00424	CcSEcCtD
Metolazone—Pancreatitis—Triamcinolone—psoriatic arthritis	0.00414	0.00414	CcSEcCtD
Metolazone—Pancreatitis—Methylprednisolone—psoriatic arthritis	0.00413	0.00413	CcSEcCtD
Metolazone—Dry skin—Betamethasone—psoriatic arthritis	0.00406	0.00406	CcSEcCtD
Metolazone—Dry skin—Dexamethasone—psoriatic arthritis	0.00406	0.00406	CcSEcCtD
Metolazone—Hypokalaemia—Dexamethasone—psoriatic arthritis	0.00403	0.00403	CcSEcCtD
Metolazone—Hypokalaemia—Betamethasone—psoriatic arthritis	0.00403	0.00403	CcSEcCtD
Metolazone—Neuropathy peripheral—Prednisolone—psoriatic arthritis	0.00401	0.00401	CcSEcCtD
Metolazone—Purpura—Prednisone—psoriatic arthritis	0.004	0.004	CcSEcCtD
Metolazone—Lethargy—Prednisone—psoriatic arthritis	0.00394	0.00394	CcSEcCtD
Metolazone—Neuropathy peripheral—Triamcinolone—psoriatic arthritis	0.00369	0.00369	CcSEcCtD
Metolazone—Neuropathy peripheral—Methylprednisolone—psoriatic arthritis	0.00368	0.00368	CcSEcCtD
Metolazone—Photosensitivity—Methotrexate—psoriatic arthritis	0.00367	0.00367	CcSEcCtD
Metolazone—Epistaxis—Triamcinolone—psoriatic arthritis	0.00355	0.00355	CcSEcCtD
Metolazone—Dry skin—Prednisone—psoriatic arthritis	0.00353	0.00353	CcSEcCtD
Metolazone—Hypokalaemia—Prednisone—psoriatic arthritis	0.00351	0.00351	CcSEcCtD
Metolazone—Hyperglycaemia—Betamethasone—psoriatic arthritis	0.00345	0.00345	CcSEcCtD
Metolazone—Hyperglycaemia—Dexamethasone—psoriatic arthritis	0.00345	0.00345	CcSEcCtD
Metolazone—Abdominal distension—Prednisone—psoriatic arthritis	0.00336	0.00336	CcSEcCtD
Metolazone—Neuropathy peripheral—Dexamethasone—psoriatic arthritis	0.00334	0.00334	CcSEcCtD
Metolazone—Neuropathy peripheral—Betamethasone—psoriatic arthritis	0.00334	0.00334	CcSEcCtD
Metolazone—Lethargy—Methotrexate—psoriatic arthritis	0.00329	0.00329	CcSEcCtD
Metolazone—Pancreatitis—Prednisone—psoriatic arthritis	0.00327	0.00327	CcSEcCtD
Metolazone—Erectile dysfunction—Prednisone—psoriatic arthritis	0.00307	0.00307	CcSEcCtD
Metolazone—Vision blurred—Prednisolone—psoriatic arthritis	0.00301	0.00301	CcSEcCtD
Metolazone—Hyperglycaemia—Prednisone—psoriatic arthritis	0.00301	0.00301	CcSEcCtD
Metolazone—Ill-defined disorder—Prednisolone—psoriatic arthritis	0.00297	0.00297	CcSEcCtD
Metolazone—Neuropathy peripheral—Prednisone—psoriatic arthritis	0.00291	0.00291	CcSEcCtD
Metolazone—Toxic epidermal necrolysis—Methotrexate—psoriatic arthritis	0.0029	0.0029	CcSEcCtD
Metolazone—Malaise—Prednisolone—psoriatic arthritis	0.00288	0.00288	CcSEcCtD
Metolazone—Dysgeusia—Triamcinolone—psoriatic arthritis	0.00288	0.00288	CcSEcCtD
Metolazone—Vertigo—Prednisolone—psoriatic arthritis	0.00287	0.00287	CcSEcCtD
Metolazone—Syncope—Prednisolone—psoriatic arthritis	0.00287	0.00287	CcSEcCtD
Metolazone—Back pain—Triamcinolone—psoriatic arthritis	0.00284	0.00284	CcSEcCtD
Metolazone—Loss of consciousness—Prednisolone—psoriatic arthritis	0.00281	0.00281	CcSEcCtD
Metolazone—Hypertension—Prednisolone—psoriatic arthritis	0.00276	0.00276	CcSEcCtD
Metolazone—Pancreatitis—Methotrexate—psoriatic arthritis	0.00273	0.00273	CcSEcCtD
Metolazone—Ill-defined disorder—Triamcinolone—psoriatic arthritis	0.00273	0.00273	CcSEcCtD
Metolazone—Ill-defined disorder—Methylprednisolone—psoriatic arthritis	0.00272	0.00272	CcSEcCtD
Metolazone—Discomfort—Prednisolone—psoriatic arthritis	0.00269	0.00269	CcSEcCtD
Metolazone—Abdominal discomfort—Methotrexate—psoriatic arthritis	0.00267	0.00267	CcSEcCtD
Metolazone—Malaise—Triamcinolone—psoriatic arthritis	0.00265	0.00265	CcSEcCtD
Metolazone—Malaise—Methylprednisolone—psoriatic arthritis	0.00264	0.00264	CcSEcCtD
Metolazone—Vertigo—Triamcinolone—psoriatic arthritis	0.00264	0.00264	CcSEcCtD
Metolazone—Syncope—Triamcinolone—psoriatic arthritis	0.00264	0.00264	CcSEcCtD
Metolazone—Vertigo—Methylprednisolone—psoriatic arthritis	0.00263	0.00263	CcSEcCtD
Metolazone—Syncope—Methylprednisolone—psoriatic arthritis	0.00263	0.00263	CcSEcCtD
Metolazone—Loss of consciousness—Triamcinolone—psoriatic arthritis	0.00258	0.00258	CcSEcCtD
Metolazone—Loss of consciousness—Methylprednisolone—psoriatic arthritis	0.00258	0.00258	CcSEcCtD
Metolazone—Shock—Prednisolone—psoriatic arthritis	0.00257	0.00257	CcSEcCtD
Metolazone—Erectile dysfunction—Methotrexate—psoriatic arthritis	0.00257	0.00257	CcSEcCtD
Metolazone—Cough—Triamcinolone—psoriatic arthritis	0.00256	0.00256	CcSEcCtD
Metolazone—Photosensitivity reaction—Methotrexate—psoriatic arthritis	0.00254	0.00254	CcSEcCtD
Metolazone—Hypertension—Triamcinolone—psoriatic arthritis	0.00254	0.00254	CcSEcCtD
Metolazone—Hypertension—Methylprednisolone—psoriatic arthritis	0.00253	0.00253	CcSEcCtD
Metolazone—Arthralgia—Methylprednisolone—psoriatic arthritis	0.0025	0.0025	CcSEcCtD
Metolazone—Anxiety—Methylprednisolone—psoriatic arthritis	0.00249	0.00249	CcSEcCtD
Metolazone—Drowsiness—Methotrexate—psoriatic arthritis	0.00248	0.00248	CcSEcCtD
Metolazone—Ill-defined disorder—Betamethasone—psoriatic arthritis	0.00247	0.00247	CcSEcCtD
Metolazone—Ill-defined disorder—Dexamethasone—psoriatic arthritis	0.00247	0.00247	CcSEcCtD
Metolazone—Discomfort—Triamcinolone—psoriatic arthritis	0.00247	0.00247	CcSEcCtD
Metolazone—Discomfort—Methylprednisolone—psoriatic arthritis	0.00247	0.00247	CcSEcCtD
Metolazone—Stevens-Johnson syndrome—Methotrexate—psoriatic arthritis	0.00246	0.00246	CcSEcCtD
Metolazone—Dry mouth—Triamcinolone—psoriatic arthritis	0.00245	0.00245	CcSEcCtD
Metolazone—Malaise—Betamethasone—psoriatic arthritis	0.0024	0.0024	CcSEcCtD
Metolazone—Malaise—Dexamethasone—psoriatic arthritis	0.0024	0.0024	CcSEcCtD
Metolazone—Vertigo—Betamethasone—psoriatic arthritis	0.0024	0.0024	CcSEcCtD
Metolazone—Vertigo—Dexamethasone—psoriatic arthritis	0.0024	0.0024	CcSEcCtD
Metolazone—Syncope—Dexamethasone—psoriatic arthritis	0.00239	0.00239	CcSEcCtD
Metolazone—Syncope—Betamethasone—psoriatic arthritis	0.00239	0.00239	CcSEcCtD
Metolazone—Shock—Triamcinolone—psoriatic arthritis	0.00236	0.00236	CcSEcCtD
Metolazone—Insomnia—Prednisolone—psoriatic arthritis	0.00236	0.00236	CcSEcCtD
Metolazone—Shock—Methylprednisolone—psoriatic arthritis	0.00235	0.00235	CcSEcCtD
Metolazone—Loss of consciousness—Betamethasone—psoriatic arthritis	0.00234	0.00234	CcSEcCtD
Metolazone—Loss of consciousness—Dexamethasone—psoriatic arthritis	0.00234	0.00234	CcSEcCtD
Metolazone—Epistaxis—Methotrexate—psoriatic arthritis	0.00234	0.00234	CcSEcCtD
Metolazone—Paraesthesia—Prednisolone—psoriatic arthritis	0.00234	0.00234	CcSEcCtD
Metolazone—Agranulocytosis—Methotrexate—psoriatic arthritis	0.00232	0.00232	CcSEcCtD
Metolazone—Hypertension—Betamethasone—psoriatic arthritis	0.0023	0.0023	CcSEcCtD
Metolazone—Hypertension—Dexamethasone—psoriatic arthritis	0.0023	0.0023	CcSEcCtD
Metolazone—Anxiety—Dexamethasone—psoriatic arthritis	0.00226	0.00226	CcSEcCtD
Metolazone—Anxiety—Betamethasone—psoriatic arthritis	0.00226	0.00226	CcSEcCtD
Metolazone—Discomfort—Dexamethasone—psoriatic arthritis	0.00224	0.00224	CcSEcCtD
Metolazone—Discomfort—Betamethasone—psoriatic arthritis	0.00224	0.00224	CcSEcCtD
Metolazone—Pain—Prednisolone—psoriatic arthritis	0.00223	0.00223	CcSEcCtD
Metolazone—Hepatitis—Methotrexate—psoriatic arthritis	0.00223	0.00223	CcSEcCtD
Metolazone—Vision blurred—Prednisone—psoriatic arthritis	0.00219	0.00219	CcSEcCtD
Metolazone—Musculoskeletal discomfort—Triamcinolone—psoriatic arthritis	0.00219	0.00219	CcSEcCtD
Metolazone—Musculoskeletal discomfort—Methylprednisolone—psoriatic arthritis	0.00218	0.00218	CcSEcCtD
Metolazone—Insomnia—Triamcinolone—psoriatic arthritis	0.00217	0.00217	CcSEcCtD
Metolazone—Insomnia—Methylprednisolone—psoriatic arthritis	0.00216	0.00216	CcSEcCtD
Metolazone—Ill-defined disorder—Prednisone—psoriatic arthritis	0.00215	0.00215	CcSEcCtD
Metolazone—Paraesthesia—Triamcinolone—psoriatic arthritis	0.00215	0.00215	CcSEcCtD
Metolazone—Feeling abnormal—Prednisolone—psoriatic arthritis	0.00215	0.00215	CcSEcCtD
Metolazone—Paraesthesia—Methylprednisolone—psoriatic arthritis	0.00215	0.00215	CcSEcCtD
Metolazone—Anaemia—Prednisone—psoriatic arthritis	0.00215	0.00215	CcSEcCtD
Metolazone—Shock—Betamethasone—psoriatic arthritis	0.00214	0.00214	CcSEcCtD
Metolazone—Shock—Dexamethasone—psoriatic arthritis	0.00214	0.00214	CcSEcCtD
Metolazone—Agitation—Prednisone—psoriatic arthritis	0.00213	0.00213	CcSEcCtD
Metolazone—Thrombocytopenia—Dexamethasone—psoriatic arthritis	0.00213	0.00213	CcSEcCtD
Metolazone—Thrombocytopenia—Betamethasone—psoriatic arthritis	0.00213	0.00213	CcSEcCtD
Metolazone—Dyspepsia—Triamcinolone—psoriatic arthritis	0.00211	0.00211	CcSEcCtD
Metolazone—Erythema multiforme—Methotrexate—psoriatic arthritis	0.00211	0.00211	CcSEcCtD
Metolazone—Dyspepsia—Methylprednisolone—psoriatic arthritis	0.00211	0.00211	CcSEcCtD
Metolazone—Malaise—Prednisone—psoriatic arthritis	0.00209	0.00209	CcSEcCtD
Metolazone—Vertigo—Prednisone—psoriatic arthritis	0.00209	0.00209	CcSEcCtD
Metolazone—Syncope—Prednisone—psoriatic arthritis	0.00208	0.00208	CcSEcCtD
Metolazone—Tinnitus—Methotrexate—psoriatic arthritis	0.00208	0.00208	CcSEcCtD
Metolazone—Anorexia—Dexamethasone—psoriatic arthritis	0.00207	0.00207	CcSEcCtD
Metolazone—Anorexia—Betamethasone—psoriatic arthritis	0.00207	0.00207	CcSEcCtD
Metolazone—Urticaria—Prednisolone—psoriatic arthritis	0.00207	0.00207	CcSEcCtD
Metolazone—Fatigue—Triamcinolone—psoriatic arthritis	0.00207	0.00207	CcSEcCtD
Metolazone—Fatigue—Methylprednisolone—psoriatic arthritis	0.00206	0.00206	CcSEcCtD
Metolazone—Pain—Triamcinolone—psoriatic arthritis	0.00205	0.00205	CcSEcCtD
Metolazone—Loss of consciousness—Prednisone—psoriatic arthritis	0.00204	0.00204	CcSEcCtD
Metolazone—Hypertension—Prednisone—psoriatic arthritis	0.002	0.002	CcSEcCtD
Metolazone—Chills—Methotrexate—psoriatic arthritis	0.002	0.002	CcSEcCtD
Metolazone—Musculoskeletal discomfort—Betamethasone—psoriatic arthritis	0.00198	0.00198	CcSEcCtD
Metolazone—Musculoskeletal discomfort—Dexamethasone—psoriatic arthritis	0.00198	0.00198	CcSEcCtD
Metolazone—Arthralgia—Prednisone—psoriatic arthritis	0.00198	0.00198	CcSEcCtD
Metolazone—Feeling abnormal—Triamcinolone—psoriatic arthritis	0.00198	0.00198	CcSEcCtD
Metolazone—Feeling abnormal—Methylprednisolone—psoriatic arthritis	0.00197	0.00197	CcSEcCtD
Metolazone—Anxiety—Prednisone—psoriatic arthritis	0.00197	0.00197	CcSEcCtD
Metolazone—Insomnia—Betamethasone—psoriatic arthritis	0.00197	0.00197	CcSEcCtD
Metolazone—Insomnia—Dexamethasone—psoriatic arthritis	0.00197	0.00197	CcSEcCtD
Metolazone—Gastrointestinal pain—Methylprednisolone—psoriatic arthritis	0.00196	0.00196	CcSEcCtD
Metolazone—Paraesthesia—Betamethasone—psoriatic arthritis	0.00195	0.00195	CcSEcCtD
Metolazone—Paraesthesia—Dexamethasone—psoriatic arthritis	0.00195	0.00195	CcSEcCtD
Metolazone—Discomfort—Prednisone—psoriatic arthritis	0.00195	0.00195	CcSEcCtD
Metolazone—Hypersensitivity—Prednisolone—psoriatic arthritis	0.00192	0.00192	CcSEcCtD
Metolazone—Dyspepsia—Betamethasone—psoriatic arthritis	0.00192	0.00192	CcSEcCtD
Metolazone—Dyspepsia—Dexamethasone—psoriatic arthritis	0.00192	0.00192	CcSEcCtD
Metolazone—Urticaria—Triamcinolone—psoriatic arthritis	0.00191	0.00191	CcSEcCtD
Metolazone—Urticaria—Methylprednisolone—psoriatic arthritis	0.0019	0.0019	CcSEcCtD
Metolazone—Dysgeusia—Methotrexate—psoriatic arthritis	0.0019	0.0019	CcSEcCtD
Metolazone—Abdominal pain—Methylprednisolone—psoriatic arthritis	0.00189	0.00189	CcSEcCtD
Metolazone—Decreased appetite—Dexamethasone—psoriatic arthritis	0.00189	0.00189	CcSEcCtD
Metolazone—Decreased appetite—Betamethasone—psoriatic arthritis	0.00189	0.00189	CcSEcCtD
Metolazone—Back pain—Methotrexate—psoriatic arthritis	0.00188	0.00188	CcSEcCtD
Metolazone—Fatigue—Betamethasone—psoriatic arthritis	0.00188	0.00188	CcSEcCtD
Metolazone—Fatigue—Dexamethasone—psoriatic arthritis	0.00188	0.00188	CcSEcCtD
Metolazone—Shock—Prednisone—psoriatic arthritis	0.00186	0.00186	CcSEcCtD
Metolazone—Pain—Dexamethasone—psoriatic arthritis	0.00186	0.00186	CcSEcCtD
Metolazone—Pain—Betamethasone—psoriatic arthritis	0.00186	0.00186	CcSEcCtD
Metolazone—Vision blurred—Methotrexate—psoriatic arthritis	0.00183	0.00183	CcSEcCtD
Metolazone—Anorexia—Prednisone—psoriatic arthritis	0.00181	0.00181	CcSEcCtD
Metolazone—Ill-defined disorder—Methotrexate—psoriatic arthritis	0.0018	0.0018	CcSEcCtD
Metolazone—Anaemia—Methotrexate—psoriatic arthritis	0.00179	0.00179	CcSEcCtD
Metolazone—Feeling abnormal—Betamethasone—psoriatic arthritis	0.00179	0.00179	CcSEcCtD
Metolazone—Feeling abnormal—Dexamethasone—psoriatic arthritis	0.00179	0.00179	CcSEcCtD
Metolazone—Gastrointestinal pain—Dexamethasone—psoriatic arthritis	0.00178	0.00178	CcSEcCtD
Metolazone—Gastrointestinal pain—Betamethasone—psoriatic arthritis	0.00178	0.00178	CcSEcCtD
Metolazone—Hypersensitivity—Triamcinolone—psoriatic arthritis	0.00177	0.00177	CcSEcCtD
Metolazone—Hypersensitivity—Methylprednisolone—psoriatic arthritis	0.00176	0.00176	CcSEcCtD
Metolazone—Malaise—Methotrexate—psoriatic arthritis	0.00175	0.00175	CcSEcCtD
Metolazone—Vertigo—Methotrexate—psoriatic arthritis	0.00174	0.00174	CcSEcCtD
Metolazone—Leukopenia—Methotrexate—psoriatic arthritis	0.00174	0.00174	CcSEcCtD
Metolazone—Urticaria—Dexamethasone—psoriatic arthritis	0.00173	0.00173	CcSEcCtD
Metolazone—Urticaria—Betamethasone—psoriatic arthritis	0.00173	0.00173	CcSEcCtD
Metolazone—Musculoskeletal discomfort—Prednisone—psoriatic arthritis	0.00173	0.00173	CcSEcCtD
Metolazone—Dizziness—Prednisolone—psoriatic arthritis	0.00172	0.00172	CcSEcCtD
Metolazone—Asthenia—Triamcinolone—psoriatic arthritis	0.00172	0.00172	CcSEcCtD
Metolazone—Abdominal pain—Dexamethasone—psoriatic arthritis	0.00172	0.00172	CcSEcCtD
Metolazone—Abdominal pain—Betamethasone—psoriatic arthritis	0.00172	0.00172	CcSEcCtD
Metolazone—Asthenia—Methylprednisolone—psoriatic arthritis	0.00172	0.00172	CcSEcCtD
Metolazone—Insomnia—Prednisone—psoriatic arthritis	0.00171	0.00171	CcSEcCtD
Metolazone—Paraesthesia—Prednisone—psoriatic arthritis	0.0017	0.0017	CcSEcCtD
Metolazone—Pruritus—Triamcinolone—psoriatic arthritis	0.0017	0.0017	CcSEcCtD
Metolazone—Cough—Methotrexate—psoriatic arthritis	0.00169	0.00169	CcSEcCtD
Metolazone—Pruritus—Methylprednisolone—psoriatic arthritis	0.00169	0.00169	CcSEcCtD
Metolazone—Dyspepsia—Prednisone—psoriatic arthritis	0.00167	0.00167	CcSEcCtD
Metolazone—Chest pain—Methotrexate—psoriatic arthritis	0.00165	0.00165	CcSEcCtD
Metolazone—Arthralgia—Methotrexate—psoriatic arthritis	0.00165	0.00165	CcSEcCtD
Metolazone—Decreased appetite—Prednisone—psoriatic arthritis	0.00165	0.00165	CcSEcCtD
Metolazone—Rash—Prednisolone—psoriatic arthritis	0.00164	0.00164	CcSEcCtD
Metolazone—Dermatitis—Prednisolone—psoriatic arthritis	0.00164	0.00164	CcSEcCtD
Metolazone—Diarrhoea—Methylprednisolone—psoriatic arthritis	0.00164	0.00164	CcSEcCtD
Metolazone—Fatigue—Prednisone—psoriatic arthritis	0.00163	0.00163	CcSEcCtD
Metolazone—Headache—Prednisolone—psoriatic arthritis	0.00163	0.00163	CcSEcCtD
Metolazone—Discomfort—Methotrexate—psoriatic arthritis	0.00163	0.00163	CcSEcCtD
Metolazone—Constipation—Prednisone—psoriatic arthritis	0.00162	0.00162	CcSEcCtD
Metolazone—Dizziness—Triamcinolone—psoriatic arthritis	0.00159	0.00159	CcSEcCtD
Metolazone—Dizziness—Methylprednisolone—psoriatic arthritis	0.00158	0.00158	CcSEcCtD
Metolazone—Feeling abnormal—Prednisone—psoriatic arthritis	0.00156	0.00156	CcSEcCtD
Metolazone—Asthenia—Betamethasone—psoriatic arthritis	0.00156	0.00156	CcSEcCtD
Metolazone—Asthenia—Dexamethasone—psoriatic arthritis	0.00156	0.00156	CcSEcCtD
Metolazone—Thrombocytopenia—Methotrexate—psoriatic arthritis	0.00155	0.00155	CcSEcCtD
Metolazone—Gastrointestinal pain—Prednisone—psoriatic arthritis	0.00155	0.00155	CcSEcCtD
Metolazone—Nausea—Prednisolone—psoriatic arthritis	0.00155	0.00155	CcSEcCtD
Metolazone—Pruritus—Dexamethasone—psoriatic arthritis	0.00154	0.00154	CcSEcCtD
Metolazone—Pruritus—Betamethasone—psoriatic arthritis	0.00154	0.00154	CcSEcCtD
Metolazone—Vomiting—Triamcinolone—psoriatic arthritis	0.00153	0.00153	CcSEcCtD
Metolazone—Vomiting—Methylprednisolone—psoriatic arthritis	0.00152	0.00152	CcSEcCtD
Metolazone—Rash—Triamcinolone—psoriatic arthritis	0.00151	0.00151	CcSEcCtD
Metolazone—Dermatitis—Triamcinolone—psoriatic arthritis	0.00151	0.00151	CcSEcCtD
Metolazone—Anorexia—Methotrexate—psoriatic arthritis	0.00151	0.00151	CcSEcCtD
Metolazone—Rash—Methylprednisolone—psoriatic arthritis	0.00151	0.00151	CcSEcCtD
Metolazone—Dermatitis—Methylprednisolone—psoriatic arthritis	0.00151	0.00151	CcSEcCtD
Metolazone—Urticaria—Prednisone—psoriatic arthritis	0.00151	0.00151	CcSEcCtD
Metolazone—Headache—Triamcinolone—psoriatic arthritis	0.0015	0.0015	CcSEcCtD
Metolazone—Headache—Methylprednisolone—psoriatic arthritis	0.0015	0.0015	CcSEcCtD
Metolazone—Abdominal pain—Prednisone—psoriatic arthritis	0.0015	0.0015	CcSEcCtD
Metolazone—Diarrhoea—Dexamethasone—psoriatic arthritis	0.00149	0.00149	CcSEcCtD
Metolazone—Diarrhoea—Betamethasone—psoriatic arthritis	0.00149	0.00149	CcSEcCtD
Metolazone—Musculoskeletal discomfort—Methotrexate—psoriatic arthritis	0.00144	0.00144	CcSEcCtD
Metolazone—Dizziness—Dexamethasone—psoriatic arthritis	0.00144	0.00144	CcSEcCtD
Metolazone—Dizziness—Betamethasone—psoriatic arthritis	0.00144	0.00144	CcSEcCtD
Metolazone—Insomnia—Methotrexate—psoriatic arthritis	0.00143	0.00143	CcSEcCtD
Metolazone—Nausea—Triamcinolone—psoriatic arthritis	0.00142	0.00142	CcSEcCtD
Metolazone—Paraesthesia—Methotrexate—psoriatic arthritis	0.00142	0.00142	CcSEcCtD
Metolazone—Nausea—Methylprednisolone—psoriatic arthritis	0.00142	0.00142	CcSEcCtD
Metolazone—Somnolence—Methotrexate—psoriatic arthritis	0.00141	0.00141	CcSEcCtD
Metolazone—Hypersensitivity—Prednisone—psoriatic arthritis	0.0014	0.0014	CcSEcCtD
Metolazone—Dyspepsia—Methotrexate—psoriatic arthritis	0.00139	0.00139	CcSEcCtD
Metolazone—Vomiting—Betamethasone—psoriatic arthritis	0.00138	0.00138	CcSEcCtD
Metolazone—Vomiting—Dexamethasone—psoriatic arthritis	0.00138	0.00138	CcSEcCtD
Metolazone—Decreased appetite—Methotrexate—psoriatic arthritis	0.00138	0.00138	CcSEcCtD
Metolazone—Rash—Betamethasone—psoriatic arthritis	0.00137	0.00137	CcSEcCtD
Metolazone—Rash—Dexamethasone—psoriatic arthritis	0.00137	0.00137	CcSEcCtD
Metolazone—Dermatitis—Betamethasone—psoriatic arthritis	0.00137	0.00137	CcSEcCtD
Metolazone—Dermatitis—Dexamethasone—psoriatic arthritis	0.00137	0.00137	CcSEcCtD
Metolazone—Fatigue—Methotrexate—psoriatic arthritis	0.00137	0.00137	CcSEcCtD
Metolazone—Headache—Betamethasone—psoriatic arthritis	0.00136	0.00136	CcSEcCtD
Metolazone—Headache—Dexamethasone—psoriatic arthritis	0.00136	0.00136	CcSEcCtD
Metolazone—Asthenia—Prednisone—psoriatic arthritis	0.00136	0.00136	CcSEcCtD
Metolazone—Pain—Methotrexate—psoriatic arthritis	0.00135	0.00135	CcSEcCtD
Metolazone—Pruritus—Prednisone—psoriatic arthritis	0.00134	0.00134	CcSEcCtD
Metolazone—Feeling abnormal—Methotrexate—psoriatic arthritis	0.00131	0.00131	CcSEcCtD
Metolazone—Diarrhoea—Prednisone—psoriatic arthritis	0.0013	0.0013	CcSEcCtD
Metolazone—Gastrointestinal pain—Methotrexate—psoriatic arthritis	0.0013	0.0013	CcSEcCtD
Metolazone—Nausea—Dexamethasone—psoriatic arthritis	0.00129	0.00129	CcSEcCtD
Metolazone—Nausea—Betamethasone—psoriatic arthritis	0.00129	0.00129	CcSEcCtD
Metolazone—Urticaria—Methotrexate—psoriatic arthritis	0.00126	0.00126	CcSEcCtD
Metolazone—Dizziness—Prednisone—psoriatic arthritis	0.00125	0.00125	CcSEcCtD
Metolazone—Abdominal pain—Methotrexate—psoriatic arthritis	0.00125	0.00125	CcSEcCtD
Metolazone—Vomiting—Prednisone—psoriatic arthritis	0.00121	0.00121	CcSEcCtD
Metolazone—Rash—Prednisone—psoriatic arthritis	0.0012	0.0012	CcSEcCtD
Metolazone—Dermatitis—Prednisone—psoriatic arthritis	0.00119	0.00119	CcSEcCtD
Metolazone—Headache—Prednisone—psoriatic arthritis	0.00119	0.00119	CcSEcCtD
Metolazone—Hypersensitivity—Methotrexate—psoriatic arthritis	0.00117	0.00117	CcSEcCtD
Metolazone—Asthenia—Methotrexate—psoriatic arthritis	0.00114	0.00114	CcSEcCtD
Metolazone—Nausea—Prednisone—psoriatic arthritis	0.00113	0.00113	CcSEcCtD
Metolazone—Pruritus—Methotrexate—psoriatic arthritis	0.00112	0.00112	CcSEcCtD
Metolazone—Diarrhoea—Methotrexate—psoriatic arthritis	0.00108	0.00108	CcSEcCtD
Metolazone—Dizziness—Methotrexate—psoriatic arthritis	0.00105	0.00105	CcSEcCtD
Metolazone—Vomiting—Methotrexate—psoriatic arthritis	0.00101	0.00101	CcSEcCtD
Metolazone—Rash—Methotrexate—psoriatic arthritis	0.000999	0.000999	CcSEcCtD
Metolazone—Dermatitis—Methotrexate—psoriatic arthritis	0.000998	0.000998	CcSEcCtD
Metolazone—Headache—Methotrexate—psoriatic arthritis	0.000992	0.000992	CcSEcCtD
Metolazone—Nausea—Methotrexate—psoriatic arthritis	0.000941	0.000941	CcSEcCtD
